Evidence map›Paper›PMID 18456662›Full record

ArticleThe Journal of biological chemistry2008

Active gene repression by the Egr2.NAB complex during peripheral nerve myelination.

Gennifer M Mager, Rebecca M Ward, Rajini Srinivasan, Sung-Wook Jang, Lawrence Wrabetz, John Svaren

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Schwann Cell Development and Myelination.Cold Spring Harbor perspectives in biology · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Molecular Mechanisms Involved in Schwann Cell Plasticity.Frontiers in molecular neuroscience · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Schwann Cells: Development and Role in Nerve Repair.Cold Spring Harbor perspectives in biology · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Gennifer M MagerMolecular and Cellular Pharmacology Training Program, Department of Comparative Biosciences, Graduate Program in Cellular and Molecular Biology, University of Wisconsin, Madison, WI 53706, USA.
Rebecca M Ward
Rajini Srinivasan
Sung-Wook Jang
Lawrence Wrabetz
John Svaren
University of Wisconsin–Madison · USVita-Salute San Raffaele University · IT

Funding

WISCONSIN CENTER ON MENTAL RETARDATION: CORE SUPPORTP30HD003352 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 1985 to 2015
$25.2M
Training Program In Molecular AND Cellular PharmacologyT32GM008688 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 1998 to 2020
$6.0M
Genetic Control of Myelination by EGR2 and NAB proteinsR01HD041590 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI SVAREN, JOHN P · 2002 to 2011
$2.8M
Pathogenesis of Myelin Protein Zero Neuropathies in Transgenic MiceR01NS055256 · NINDS · ISTITUTO SCIENTIFICO SAN RAFFAELE · PI WRABETZ, LAWRENCE · 2006 to 2010
$1.2M
NICHD NIH HHS HD 41590NICHD NIH HHS P30 HD 03352NIGMS NIH HHS T32 GM 08688NINDS NIH HHS R01 NS055256Telethon GGP07100
6 · The paper itself

Abstract

The Egr2/Krox20 transactivator is required for activation of many myelin-associated genes during peripheral nerve myelination by Schwann cells. However, recent work has indicated that Egr2 not only activates genes required for peripheral nerve myelination but may also be involved in gene repression. The NAB (NGFI-A/Egr-binding) corepressors interact with Egr2 and are required for proper coordination of myelin formation. Therefore, NAB proteins could mediate repression of some Egr2 target genes, although direct repression by Egr2 or NAB proteins during myelination has not been demonstrated. To define the physiological role of NAB corepression in gene repression by Egr2, we tested whether the Egr2.NAB complex directly repressed specific target genes. A screen for NAB-regulated genes identified several (including Id2, Id4, and Rad) that declined during the course of peripheral nerve myelination. In vivo chromatin immunoprecipitation analysis of the myelinating sciatic nerve was used to show developmental association of both Egr2 and NAB2 on the Id2, Id4, and Rad promoters as they were repressed during the myelination process. In addition, NAB2 represses transcription by interaction with the chromodomain helicase DNA-binding protein 4 (CHD4) subunit of the nucleosome remodeling and deacetylase chromatin remodeling complex, and we demonstrate that CHD4 occupies NAB-repressed promoters in a developmentally regulated manner in vivo. These results illustrate a novel aspect of genetic regulation of peripheral nerve myelination by showing that Egr2 directly represses genes during myelination in conjunction with NAB corepressors. Furthermore, repression of Id2 was found to augment activation of Mpz (myelin protein zero) expression.

Indexed as

Gene Expression RegulationAnimalsAutoantigensChromatinDNA HelicasesEarly Growth Response Protein 2Inhibitor of Differentiation Protein 2Mi-2 Nucleosome Remodeling and Deacetylase ComplexMiceMyelin SheathPeripheral NervesProtein BindingRatsRepressor ProteinsAutoantigensCHD4 protein, humanChromatinDNA HelicasesEarly Growth Response Protein 2Egr2 protein, mouseEgr2 protein, ratId2 protein, ratIdb2 protein, mouseInhibitor of Differentiation Protein 2Mi-2 Nucleosome Remodeling and Deacetylase ComplexNab1 protein, mouseNab1 protein, ratRepressor Proteins

Identifiers

PMID18456662
PMCPMC2440619
OpenAlexW1775113439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.